Worth it or not? Primary tumor resection for stage IV pancreatic cancer patients: A SEER‐based analysis of 15,836 cases-Reference-Cited by-同舟云学术

Worth it or not? Primary tumor resection for stage IV pancreatic cancer patients: A SEER‐based analysis of 15,836 cases

Published:2021-07-21 Issue:17 Volume:10 Page:5948-5963
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Fu Ningzhen¹²³⁴^ORCID,Jiang Yu¹²³⁴,Weng Yuanchi¹²³⁴,Chen Hao¹²³⁴,Deng Xiaxing¹²³⁴,Shen Baiyong¹²³⁴^ORCID

Affiliation:

1. Department of General Surgery Pancreatic Disease Center Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine Shanghai China

2. Shanghai Jiao Tong University School of MedicineResearch Institute of Pancreatic Disease Shanghai China

3. State Key Laboratory of Oncogenes and Related Genes Shanghai China

4. Shanghai Jiao Tong UniversityInstitute of Translational Medicine Shanghai China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4147

Reference26 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Pancreatic cancer

3. Nab-paclitaxel plus gemcitabine versus FOLFIRINOX as the first-line chemotherapy for patients with metastatic pancreatic cancer: retrospective analysis

4. FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

5. Eligibility of Metastatic Pancreatic Cancer Patients for First-Line Palliative Intent nab-Paclitaxel Plus Gemcitabine Versus FOLFIRINOX

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishment of a nomogram model for predicting distant metastasis in pancreatic ductal adenocarcinoma: a comparative analysis of different lymph node staging systems based on the SEER database;Scientific Reports;2024-08-05

2. Combining single-cell and bulk RNA sequencing, NK cell marker genes reveal a prognostic and immune status in pancreatic ductal adenocarcinoma;Scientific Reports;2024-07-01

3. The Value of Primary Tumor Resection among Different Treatment Methods in Stage IV Breast Cancer: Robust Evidence for Prognostic Benefit;2023-11-17

4. Primary Tumor Resection for Metastatic Colorectal, Gastric and Pancreatic Cancer Patients: In Search of Scientific Evidence to Inform Clinical Practice;Cancers;2023-01-31

5. 進行癌症例に対する霊梅散（WTMCGEP）の治療効果;Kampo Medicine;2023